A new mass spectrometry platform for membrane protein lipid interactions (360G-Wellcome-104633_Z_14_A)
The motivation for a second instrument is that it has enhanced capabilities and will permit many critical experiments that are currently not possible. We have contributed to the design stage of this instrument which will be launched in September 2016. This second generation Orbitrap Q-Exactive is capable of performing tandem MS studies to identify lipids bound directly to membrane proteins. With current technology these lipids can be observed attached to the protein but their identification is not possible. Our research group is at the forefront of these developments worldwide and we believe it is important for us to retain this position. not just for UK Science and Technology, but also for start-up companies, UK Biotech and SMEs.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 150000 |
| Applicant Surname | Robinson |
| Approval Committee | Science Enhancement Committee |
| Award Date | 2016-08-04T00:00:00+00:00 |
| Financial Year | 2015/16 |
| Grant Programme: Title | Enhancement |
| Internal ID | 104633/Z/14/A |
| Lead Applicant | Prof Dame Carol Robinson |
| Partnership Value | 150000 |
| Planned Dates: End Date | 2021-03-01T00:00:00+00:00 |
| Planned Dates: Start Date | 2016-09-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | South East |